| Literature DB >> 12957465 |
A Sánchez1, P Nagy, S S Thorgeirsson.
Abstract
The signal transducer and activator of transcription (STAT)-3 regulates basic biological processes and it has been reported to be constitutively active in different types of malignant tumours. STAT-3 is active during the regenerative growth of the liver, but there are hardly any data about its presence in liver tumours. We investigated and found a high activity of STAT-3 using an electrophoretic mobility shift assay (EMSA) in chemically-induced rat hepatocellular carcinomas (HCCs). Dexamethasone treatment downregulated both STAT-3 activity and cell proliferation in the tumours. Therefore, the activity of the STAT-3 signal transduction pathway seems to be required for the growth of HCCs and could be a potential new target for therapeutic trials of this tumour type.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12957465 DOI: 10.1016/s0959-8049(03)00393-9
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162